Status:
RECRUITING
PsoBest - The German Psoriasis Registry
Lead Sponsor:
Universitätsklinikum Hamburg-Eppendorf
Collaborating Sponsors:
Berufsverband der Deutschen Dermatologen e.V. (www.bvdd.de)
Deutsche Dermatologische Gesellschaft e.V. (https://derma.de)
Conditions:
Psoriasis
Psoriatic-arthritis
Eligibility:
All Genders
18+ years
Brief Summary
Treatment of moderate to severe Psoriasis (Pso) and Psoriasis-Arthritis (PsA) is largely confined to systemic therapy in Germany. Systemic therapy includes conventional systemic therapy (e.g. fumaric ...
Detailed Description
Background: Treatment of moderate to severe Psoriasis (Pso) and Psoriasis-Arthritis (PsA) is largely confined to systemic therapy in Germany. Systemic therapy includes conventional systemic therapy (e...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- patients with diagnosis of plaque-type psoriasis or psoriasis arthritis confirmed by a dermatologist
- age ≥ 18 years
- being administered a specific systemic drug for the first time
- informed consent to participate
- sufficient language skills (German)
- Exclusion criteria:
- lack of informed consent
- patients being participants of clinical trials at the day of admission to the registry (if a patient is included into a clinical trial during the registry follow-ups, the patient data will be recorded, but analysed separately)
Exclusion
Key Trial Info
Start Date :
January 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2032
Estimated Enrollment :
3500 Patients enrolled
Trial Details
Trial ID
NCT01848028
Start Date
January 1 2008
End Date
December 1 2032
Last Update
January 27 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nationwide group of dermatological centers, hospitals and medical offices
Hamburg, Germany